Bingyi Yang

7PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyCancer geneticsEnvironmental epidemiologyReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 01, 2025
Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling.

Jiali Hu, Lulu Wang, Bingyi Yang

|Jul 07, 2025
Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment.

Yali Cheng, Youting Dong, Bingyi Yang

|Dec 23, 2022
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914).

Zhiying Xu, Bingyi Yang, Jun Guan

|Jun 04, 2021
Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment.

Shuang Zhou, Zhiying Xu, Bingyi Yang

|Feb 12, 2019
Asian Society of Gynecologic Oncology International Workshop 2018.

Tae Wook Kong, Hee Sug Ryu, Seung Cheol Kim

|Nov 28, 2018
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.

Jun Guan, Liying Xie, Xuezhen Luo

Pageof 2

Frequent Collaborators

6 joint publications

Xiaojun Chen

3 joint publications

Weiwei Shan

3 joint publications

Jun Guan

2 joint publications

Liying Xie